Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules
暂无分享,去创建一个
Jayvee R. Abella | Kyle R Jackson | L. Kavraki | S. Justesen | P. Hwu | D. Antunes | M. Rigo | G. Lizée | D. Hawke | J. Roszik | D. Lopez-Ferrer | Aman Makaju | A. Huhmer | Y. Chiu | A. Talukder | F. Frenkel | Brenda D. Melendez | Fenge Li | Y. Sun | H. Sonnemann | A. Katailiha | R. Fasoulis | Avery J. Salmon | Ariana R Maleki | Kano Amagai | V. Belousov | Yang Liu | David Horn | Yulun Chiu | Avery Salmon
[1] N. Salomonis,et al. DeepImmuno: Deep learning-empowered prediction and generation of immunogenic peptides for T cell immunity , 2020, bioRxiv.
[2] S. Justesen,et al. Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools , 2020, Scientific Reports.
[3] Jayvee R. Abella,et al. Markov state modeling reveals alternative unbinding pathways for peptide–MHC complexes , 2020, Proceedings of the National Academy of Sciences.
[4] Jayvee R. Abella,et al. Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G , 2020, Frontiers in Immunology.
[5] Kyle R Jackson,et al. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers , 2020, Nature Communications.
[6] Conrad C. Huang,et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.
[7] J. Yewdell,et al. A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion , 2020, Nature Reviews Immunology.
[8] Alex Rubinsteyn,et al. MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing. , 2020, Cell systems.
[9] Morten Nielsen,et al. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data , 2020, Nucleic Acids Res..
[10] V. Velculescu,et al. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets , 2019, Cancer Immunology Research.
[11] N. Hacohen,et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population , 2019, Nature Biotechnology.
[12] Katherine Luzuriaga,et al. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection , 2019, PLoS pathogens.
[13] G. Gao,et al. Salt bridge-forming residues positioned over viral peptides presented by MHC class I impacts T-cell recognition in a binding-dependent manner , 2019, Molecular Immunology.
[14] Alessandro Sette,et al. The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..
[15] Alex Rubinsteyn,et al. MHCflurry: Open-Source Class I MHC Binding Affinity Prediction. , 2018, Cell systems.
[16] Peter V Coveney,et al. Uncertainty Quantification in Alchemical Free Energy Methods , 2018, Journal of chemical theory and computation.
[17] Sri H. Ramarathinam,et al. The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis , 2018, The Journal of Biological Chemistry.
[18] Lydia E. Kavraki,et al. Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy , 2017, Front. Immunol..
[19] Z. Weng,et al. Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes , 2017, The Journal of Immunology.
[20] David Gfeller,et al. Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity , 2017, bioRxiv.
[21] Didier Devaurs,et al. Coarse-Grained Conformational Sampling of Protein Structure Improves the Fit to Experimental Hydrogen-Exchange Data , 2017, Front. Mol. Biosci..
[22] Jennifer G. Abelin,et al. Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.
[23] M. Nielsen,et al. Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01 , 2017, The Journal of Biological Chemistry.
[24] Haruki Nakamura,et al. Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive. , 2017, Methods in molecular biology.
[25] F. Pazos,et al. A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens* , 2016, Molecular & Cellular Proteomics.
[26] David Gfeller,et al. Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide–HLA Interactions , 2016, The Journal of Immunology.
[27] Zhiping Weng,et al. How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire , 2016, Proceedings of the National Academy of Sciences.
[28] Thomas J Lane,et al. MDTraj: a modern, open library for the analysis of molecular dynamics trajectories , 2014, bioRxiv.
[29] J. E. Brewer,et al. NY-ESO-1 specific TCR engineered T-cells mediate sustained antigen-specific antitumor effects in myeloma , 2015, Nature Medicine.
[30] F. Noé,et al. Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models , 2015, Nature Communications.
[31] Charlotte M. Deane,et al. Rapid, Precise, and Reproducible Prediction of Peptide-MHC Binding Affinities from Molecular Dynamics That Correlate Well with Experiment. , 2015, Journal of chemical theory and computation.
[32] C. Keşmir,et al. Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most? , 2015, Immunogenetics.
[33] James Robinson,et al. The IPD and IMGT/HLA database: allele variant databases , 2014, Nucleic Acids Res..
[34] Morten Nielsen,et al. Uncovering the Peptide-Binding Specificities of HLA-C: A General Strategy To Determine the Specificity of Any MHC Class I Molecule , 2014, The Journal of Immunology.
[35] C. Bailey-Kellogg,et al. The two-faced T cell epitope , 2013, Human vaccines & immunotherapeutics.
[36] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[37] Alexander D. MacKerell,et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. , 2012, Journal of chemical theory and computation.
[38] Morten Nielsen,et al. Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion , 2012, Nucleic Acids Res..
[39] J. McCluskey,et al. The Energetic Basis Underpinning T-cell Receptor Recognition of a Super-bulged Peptide Bound to a Major Histocompatibility Complex Class I Molecule* , 2012, The Journal of Biological Chemistry.
[40] Rainer A Böckmann,et al. Dynamical characterization of two differentially disease associated MHC class I proteins in complex with viral and self-peptides. , 2012, Journal of molecular biology.
[41] Marialva Sinigaglia,et al. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele. , 2011, Molecular immunology.
[42] Jan H. Jensen,et al. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.
[43] Cedric E. Ginestet. ggplot2: Elegant Graphics for Data Analysis , 2011 .
[44] B. Baker,et al. Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition. , 2010, Journal of medicinal chemistry.
[45] Feng Gao,et al. Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein , 2010, Journal of Virology.
[46] F. Bonilla,et al. Adaptive immunity. , 2010, The Journal of allergy and clinical immunology.
[47] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[48] Søren Buus,et al. Functional recombinant MHC class II molecules and high-throughput peptide-binding assays , 2009, Immunome research.
[49] P. van Endert,et al. Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition , 2009, Proceedings of the National Academy of Sciences.
[50] M. Nielsen,et al. Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays , 2009, Journal of biomolecular screening.
[51] J. Shabanowitz,et al. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for presentation of transformed self , 2008, Nature Immunology.
[52] M. Manns,et al. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. , 2008, Vaccine.
[53] Ettore Appella,et al. Single MHC mutation eliminates enthalpy associated with T cell receptor binding. , 2007, Journal of molecular biology.
[54] J. Evanseck,et al. Secondary anchor substitutions in an HLA-A*0201-restricted T-cell epitope derived from Her-2/neu. , 2007, Molecular immunology.
[55] G. Gao,et al. Crystal structure of HLA‐A*2402 complexed with a telomerase peptide , 2006, European journal of immunology.
[56] Natalie A Borg,et al. High Resolution Structures of Highly Bulged Viral Epitopes Bound to Major Histocompatibility Complex Class I , 2005, Journal of Biological Chemistry.
[57] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[58] Nathan A. Baker,et al. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..
[59] M. Bouvier,et al. Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. , 2004, Journal of immunology.
[60] J. Yewdell,et al. Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.
[61] B. Baker,et al. MHC Allele-Specific Molecular Features Determine Peptide/HLA-A2 Conformations That Are Recognized by HLA-A2-Restricted T Cell Receptors1 , 2002, The Journal of Immunology.
[62] Brian M. Baker,et al. Identification of a Crucial Energetic Footprint on the α1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2–Specific T Cell Receptors , 2001, The Journal of experimental medicine.
[63] S. Muta,et al. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217. , 2000, Biopolymers.
[64] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[65] B. Čatipović,et al. Peptide Binding to MHC Class I is Determined by Individual Pockets in the Binding Groove , 1997, Scandinavian journal of immunology.
[66] M F del Guercio,et al. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. , 1995, Journal of immunology.
[67] C. Schönbach,et al. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. , 1995, Journal of immunology.
[68] Paul Bowness,et al. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27 , 1994, European journal of immunology.
[69] K. Parker,et al. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding. , 1994, Biochemistry.
[70] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[71] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[72] H. Rammensee,et al. Peptide motifs of closely related HLA class I molecules encompass substantial differences , 1992, European journal of immunology.
[73] J. Coligan,et al. The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping. , 1992, Molecular immunology.
[74] J. Sacchettini,et al. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[75] A. McMichael,et al. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. , 1992, Science.
[76] T. Elliott,et al. Structural requirements for the peptide‐induced conformational change of free major histocompatibility complex class I heavy chains , 1992, European journal of immunology.
[77] J. Casanova,et al. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule. , 1992, Journal of immunology.
[78] F. Carbone. Conformational constraints involved in MHC class I restricted antigen presentation. , 1991, International reviews of immunology.
[79] J. Berzofsky,et al. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein , 1989, The Journal of experimental medicine.
[80] K. Meyer zum Büschenfelde,et al. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens , 1989, The Journal of experimental medicine.
[81] H. Grey,et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[82] W. Taylor,et al. A sequence pattern common to T cell epitopes. , 1988, The EMBO journal.
[83] E. Goulmy,et al. Y-antigen killing by T cells of women is restricted by HLA , 1977, Nature.
[84] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.